SCHEMBL6169852

SCHEMBL6169852

CCc1noc(-c2ccc(F)cc2)c1-c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 1/20 0.46
MAPK14 Q16539 1/20 0.46
PTGS2 P35354 3/20 0.43
PTGS1 P23219 1/20 0.43
PTPN1 P18031 1/20 0.43
MLYCD O95822 1/20 0.40
DHFR P00374 1/20 0.39
HEXA P06865 1/20 0.39
HEXB P07686 1/20 0.39
KDM4E B2RXH2 3/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
ALDH1A1 P00352 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
CASP3 P42574 2/20 0.38
SENP8 Q96LD8 2/20 0.38
SENP7 Q9BQF6 2/20 0.38
SENP6 Q9GZR1 1/20 0.38
MAPT P10636 1/20 0.38
DUSP3 P51452 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6169007 0.91 PTGS1 (0.50) PTGS2PTGS1PTPN1MLYCDDHFR
SCHEMBL6167853 0.84 PTGS2 (0.43) PTGS2PTGS1PTPN1MLYCDDHFR
Sulfamide SCHEMBL4639248 0.82 PTPN1 (0.46) PTGS2PTGS1PTPN1MLYCDDHFR
SCHEMBL6168431 0.81 PTGS2 (0.54) PTGS2
SCHEMBL6167808 0.81 PTGS2 (0.58) PTGS2PTGS1
SCHEMBL6170486 0.81 PTGS2 (0.58) PTGS2PTGS1
SCHEMBL6168613 0.79 PTGS2 (0.57) PTGS2PTGS1
SCHEMBL213407 0.79 PTGS2 (0.57) PTGS2PTGS1
SCHEMBL8473985 0.77 PTGS2 (0.43) MAPK10MAPK14PTGS2PTGS1
SCHEMBL8481523 0.77 PTGS2 (0.41) PTGS2PTGS1MLYCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1214790-C Medicinal composition for treating inflammation SEARLE & CO (US) 2005-08-17 CN disclosed
EP-1528059-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle LLC (US) 2005-05-04 EP disclosed
CN-1442139-A Medicinal composition for treating inflammation SEARLE & CO (US) 2003-09-17 CN disclosed
EP-0809636-B1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-09-04 EP disclosed
EP-1223167-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle & Co. (US) 2002-07-17 EP disclosed
US-5859257-A ANTIINFLAMMATORY, ANTIARTHRITIC AGENTS G. D. SEARLE & CO. (US) 1999-01-12 US disclosed